Stroke Trial, Recruiting (NCT05756257)

Stroke Trial, Recruiting NCT05756257 Sponsor: Yale University Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT05756257 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had an ischemic stroke (a stroke caused by a blocked blood vessel) as defined by the American Heart Association.
People whose CT or MRI scan shows the stroke affected the front part of the brain (frontal, parietal, or upper temporal lobes), OR whose brain artery scan shows a blockage in one of the main arteries supplying the front of the brain.
People whose stroke started within the past 48 hours, and who are able to have a special type of MRI scan within 72 hours of arriving at the hospital.
People with a stroke severity score of 4 or higher on a standard medical scale used to measure stroke symptoms (confirm with trial site).

Who may not be able to join:

People who already had significant disability or needed help with daily activities before the stroke occurred.
People whose hospital stay is expected to be shorter than 72 hours.
People who have a pacemaker or any other condition that makes having an MRI scan unsafe, as outlined by radiology safety guidelines.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Adam de Havenon, MD, Yale University

Phone: 203-785-4085

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05756257

Sponsor: Yale University

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: 203-785-4085

More information: https://clinicaltrials.gov/study/NCT05756257

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had an ischemic stroke (a stroke caused by a blocked blood vessel) as defined by the American Heart Association.
People whose CT or MRI scan shows the stroke affected the front part of the brain (frontal, parietal, or upper temporal lobes), OR whose brain artery scan shows a blockage in one of the main arteries supplying the front of the brain.
People whose stroke started within the past 48 hours, and who are able to have a special type of MRI scan within 72 hours of arriving at the hospital.
People with a stroke severity score of 4 or higher on a standard medical scale used to measure stroke symptoms (confirm with trial site).

Who may not be able to join:

People who already had significant disability or needed help with daily activities before the stroke occurred.
People whose hospital stay is expected to be shorter than 72 hours.
People who have a pacemaker or any other condition that makes having an MRI scan unsafe, as outlined by radiology safety guidelines.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Yale University

Registry

ClinicalTrials.gov

Start date

15 July 2024

Est. completion

30 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Functional outcome; Imaging outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov